Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
American Journal of Therapeutics|March 22, 2024
Psychedelic Therapy: A Primer for Primary Care Clinicians-IbogaineKirsten Cherian, Kenneth Shinozuka, Burton J Tabaac, et al.
American Journal of Therapeutics|March 22, 2024
Psychedelic Therapy: A Primer for Primary Care Clinicians-The Strengths, Weaknesses, Opportunities, and Threats of Psychedelic TherapeuticsOwen S Muir, Kenneth Shinozuka, Bryce D Beutler, et al.
American Journal of Therapeutics|March 22, 2024
Psychedelic Therapy: A Primer for Primary Care Clinicians-Lysergic Acid Diethylamide (LSD)Bryce D Beutler, Kenneth Shinozuka, Burton J Tabaac, et al.
American Journal of Therapeutics|March 22, 2024
Psychedelic Therapy: A Primer for Primary Care Clinicians-3,4-Methylenedioxy-methamphetamine (MDMA)Kenneth Shinozuka, Burton J Tabaac, Alejandro Arenas, et al.
American Journal of Therapeutics|March 22, 2024
Psychedelic Therapy: A Primer for Primary Care Clinicians-KetamineViviana D Evans, Alejandro Arenas, Kenneth Shinozuka, et al.
American Journal of Therapeutics|March 22, 2024
Psychedelic Therapy: A Primer for Primary Care Clinicians-PsilocybinBurton J Tabaac, Kenneth Shinozuka, Alejandro Arenas, et al.
American Journal of Therapeutics|March 22, 2024
Psychedelic Therapy: A Primer for Primary Care Clinicians-N,N-Dimethyltryptamine and AyahuascaKenneth Shinozuka, Burton J Tabaac, Alejandro Arenas, et al.
Journal of Vascular and Interventional Radiology : JVIR|October 20, 1999
Uterine artery embolization for the treatment of uterine leiomyomata midterm resultsS C Goodwin, B McLucas, M Lee, et al.
The Journal of Experimental Medicine|January 4, 2023
Regulatory T cells suppress CD4+ effector T cell activation by controlling protein synthesisLomon So, Kazushige Obata-Ninomiya, Alex Hu, et al.
Pageof 10